Latest filing published 12 Feb 2024 for Cyteir Therapeutics, Inc., €20k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by John F. Thero span 2 companies, the busiest being Amarin CORP Plc\uk and Cyteir Therapeutics, Inc. Over a trading history stretching from 31 December 2015 to 8 February 2024, the count stands at 10 filings.
Every open-market trade on record is a purchase: 2 purchases worth €19k, and no sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 7 option exercises.
The record was last updated on 12 February 2024 with an option exercise (€20k) in Cyteir Therapeutics, Inc. The last purchase on record was published on 12 May 2022, which is 1,620 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations